Publication:
Dihydrofolate reductase and antifolate resistance in malaria

dc.contributor.authorWorachart Sirawarapornen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-07-04T08:02:37Z
dc.date.available2018-07-04T08:02:37Z
dc.date.issued1998-12-01en_US
dc.description.abstractThe dihydrofolate reductase (DHFR, EC 1.5.1.3) domain of Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase (DHFR-TS) is an attractive target of two important antifolate antimalarials: pyrimethamine (Pyr) and cycloguanil (Cyc). Over recent years, knowledge of malarial DHFR and mechanism(s) of antifolate resistance have increased substantially. These observations have provided an important framework for better understanding the molecular basis of antifolate resistance in malaria. This article provides a brief review and update on molecular aspects relevant to antifolate resistance in malaria. © 1998 Harcourt Brace & Co. Ltd All rights reserved.en_US
dc.identifier.citationDrug Resistance Updates. Vol.1, No.6 (1998), 397-406en_US
dc.identifier.doi10.1016/S1368-7646(98)80015-0en_US
dc.identifier.issn13687646en_US
dc.identifier.other2-s2.0-0000715174en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/18273
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0000715174&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleDihydrofolate reductase and antifolate resistance in malariaen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0000715174&origin=inwarden_US

Files

Collections